COVID-19 treatment: Gilead submits New Drug Application to FDA for Remdesivir
by Press Release from Outbreak News Today on (#56S9P)
Gilead Sciences, Inc. announced Monday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury(R) (remdesivir), an investigational antiviral for the treatment of patients with COVID-19. Veklury is currently available in the U.S. under an Emergency Use Authorization for the treatment of hospitalized patients with severe COVID-19. [...]
The post COVID-19 treatment: Gilead submits New Drug Application to FDA for Remdesivir appeared first on Outbreak News Today.